Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Institutional

PFIZER & ICM partnership

Published on: 01/02/2012 Reading time: 1 min
Team PFIZER & ICM

Institut du Cerveau et de la Moelle épiniѐre (Institut du Cerveau - ICM) and Pfizer have announced a three-year scientific collaboration to investigate the fundamental mechanisms of certain neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s diseases, which are diseases with significant unmet medical need.

This collaboration brings together the Institut du Cerveau - ICM’s recognized translational medicine expertise, and Pfizer’s commitment and experience in neuroscience research in the development of medicines for neurological diseases.

 
All of the projects to be undertaken share the objective of better understanding the underlying processes which cause each disease in order to help enable the more efficient development of treatments. In some of the projects, the effects of medicines currently under development will be assessed.

 
A key study of the collaboration will aim to determine ways to identify Alzheimer’s disease patients at an early stage when future treatments which are targeted at preventing or slowing the disease might have a greater impact.

In addition, researchers at Pfizer and Institut du Cerveau - ICM will collaborate to better understand the cellular mechanisms of other neurodegenerative diseases.

Pfizer‘s website

Our news on the subject

erc
Nikolas Karalis, team leader at the Paris Brain Institute, is awarded the ERC Starting Grant 2024.
The European Research Council's (ERC) Starting Grants are prestigious and highly competitive awards, designed to enable young scientists to build their research team, and to carry out ambitious and innovative projects addressing unexplored scientific ...
09.16.2024 Institutional
L'une des présentation lors de la visite
A special international visit: members and friends of the International Olympic Committee discover Paris Brain Institute
On Wednesday July 31, the Institute had the pleasure of welcoming a special group of visitors: members of the International Olympic Committee (IOC) and their friends and families. ...
09.08.2024 Institutional
Des mains de chercheuse qui manipulent
New edition of the Big Brain Theory program for bold ideas (BBT4)
In 2024, Paris Brain Institute launched the 4th edition of the Big Brain Theory Program (BBT), designed to foster new and bold projects addressing the next challenges in neuroscience. For the first time, this call is open to our international ...
06.14.2024 Institutional
image
A 7-Tesla MRI machine at Paris Brain Institute - behind the scenes of this incredible technology
It was a long-awaited event. On Sunday June 9, 2024, Paris Brain Institute welcomed an incredible piece of technology into its facilities: the latest generation MAGNETOM Terra X (Siemens Healthineers) 7T MRI. Teams have been doing a great deal of ...
08.14.2024 Institutional
erc
Researcher from Paris Brain Institute wins 2023 European ERC Consolidator grant
The European Research Council (ERC) has just published the list of recipients of "Consolidator grants" for 2023. Nicolas RENIER, a researcher at the Institut du Cerveau, has been awarded this prestigious label. ...
11.23.2023 Institutional
erc
Three researchers from Paris Brain Institute awarded in 2023 an ERC STARTING GRANT
The European Research Council (ERC) has just published the list of recipients of “Starting grants” funding for 2023. The three candidates from Paris Brain Institute who applied to this highly competitive call for proposals have been awarded this ...
09.05.2023 Institutional
See all our news